We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFLIW icon
4501
Dragonfly Energy Holdings Warrant
DFLIW
$51.7K
$139K ﹤0.01%
+281,250
New +$127K
ADAM
4502
Adamas Trust
ADAM
$777M
$139K ﹤0.01%
8,146
-1,371
-14% -$23.9K
SKYA
4503
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$139K ﹤0.01%
+14,355
New +$139K
LVRAW
4504
DELISTED
Levere Holdings Corp. Warrant
LVRAW
$139K ﹤0.01%
161,981
+95,315
+143% +$101K
ACRO.WS
4505
DELISTED
Acropolis Infrastructure Acquisition Corp Warrants
ACRO.WS
$138K ﹤0.01%
+149,999
New +$129K
CARM
4506
DELISTED
Carisma Therapeutics
CARM
$137K ﹤0.01%
8,654
-7,745
-47% -$372K
CNVY
4507
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$136K ﹤0.01%
+16,207
New +$144K
FSNB.WS
4508
DELISTED
Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
FSNB.WS
$135K ﹤0.01%
+201,354
New +$161K
VYGG.WS
4509
DELISTED
Vy Global Growth Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
VYGG.WS
$135K ﹤0.01%
100,000
ASUR icon
4510
Asure Software
ASUR
$220M
$134K ﹤0.01%
14,852
-891
-6% -$7.83K
BDSX icon
4511
Biodesix
BDSX
$228M
$134K ﹤0.01%
814
+31
+4% +$5.88K
CTMX icon
4512
CytomX Therapeutics
CTMX
$705M
$134K ﹤0.01%
26,297
-163,147
-86% -$873K
FSM icon
4513
Fortuna Silver Mines
FSM
$2.59B
$134K ﹤0.01%
34,056
-38,140
-53% -$171K
WTTR icon
4514
Select Water Solutions
WTTR
$2.51B
$132K ﹤0.01%
25,499
-7,074
-22% -$38.9K
GACQW
4515
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
$132K ﹤0.01%
+280,000
New +$141K
ERIC icon
4516
Ericsson
ERIC
$30.7B
$131K ﹤0.01%
11,700
-15,000
-56% -$177K
ICAD
4517
DELISTED
iCAD Inc
ICAD
$131K ﹤0.01%
+12,214
New +$159K
AIRG icon
4518
Airgain
AIRG
$74.3M
$129K ﹤0.01%
+10,219
New +$160K
KAHC.WS
4519
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$129K ﹤0.01%
133,982
+50,649
+61% +$56.9K
TETCW
4520
DELISTED
Tech and Energy Transition Corporation Warrant
TETCW
$128K ﹤0.01%
196,660
+63,327
+47% +$49.9K
NGC.WS
4521
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
$128K ﹤0.01%
139,611
+83,308
+148% +$93.1K
CMO
4522
DELISTED
Capstead Mortgage Corp.
CMO
$128K ﹤0.01%
19,064
-234,734
-92% -$1.54M
AMPY icon
4523
Amplify Energy
AMPY
$163M
$127K ﹤0.01%
+23,782
New +$89.2K
DAVEW icon
4524
Dave Inc Warrants
DAVEW
$34.3M
$127K ﹤0.01%
74,463
+57,797
+347% +$96K
CLVR
4525
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$127K ﹤0.01%
+546
New +$155K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.